212 related articles for article (PubMed ID: 20309918)
1. Type 2 diabetes and cancer: what is the connection?
Cannata D; Fierz Y; Vijayakumar A; LeRoith D
Mt Sinai J Med; 2010; 77(2):197-213. PubMed ID: 20309918
[TBL] [Abstract][Full Text] [Related]
2. Clinical and molecular mechanisms favoring cancer initiation and progression in diabetic patients.
Sciacca L; Vigneri R; Tumminia A; Frasca F; Squatrito S; Frittitta L; Vigneri P
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):808-15. PubMed ID: 23932729
[TBL] [Abstract][Full Text] [Related]
3. The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas.
Giovannucci E; Michaud D
Gastroenterology; 2007 May; 132(6):2208-25. PubMed ID: 17498513
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological aspects of neoplasms in diabetes.
Nicolucci A
Acta Diabetol; 2010 Jun; 47(2):87-95. PubMed ID: 20376506
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, insulin, and risk of cancer.
Schiel R; Beltschikow W; Steiner T; Stein G
Methods Find Exp Clin Pharmacol; 2006 Apr; 28(3):169-75. PubMed ID: 16810343
[TBL] [Abstract][Full Text] [Related]
6. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes.
Govindarajan R; Ratnasinghe L; Simmons DL; Siegel ER; Midathada MV; Kim L; Kim PJ; Owens RJ; Lang NP
J Clin Oncol; 2007 Apr; 25(12):1476-81. PubMed ID: 17442990
[TBL] [Abstract][Full Text] [Related]
7. [Diabetes, insulin, insulin analogues, and cancer].
Müssig K; Staiger H; Kantartzis K; Fritsche A; Kanz L; Häring HU
Dtsch Med Wochenschr; 2010 May; 135(18):924-9. PubMed ID: 20425680
[TBL] [Abstract][Full Text] [Related]
8. [Correlations of insulin resistance and neoplasms].
Suba Z; Ujpál M
Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
[TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus type 2 - an independent risk factor for cancer?
Grote VA; Becker S; Kaaks R
Exp Clin Endocrinol Diabetes; 2010 Jan; 118(1):4-8. PubMed ID: 20127570
[TBL] [Abstract][Full Text] [Related]
10. [Serum concentration of insulin, C-peptide and insulin-like growth factor I in patients with colon adenomas and colorectal cancer].
Kaczka A; Kumor A; Pietruczuk M; Małecka-Panas E
Pol Merkur Lekarski; 2007 May; 22(131):373-5. PubMed ID: 17679371
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms linking diet and colorectal cancer: the possible role of insulin resistance.
Bruce WR; Wolever TM; Giacca A
Nutr Cancer; 2000; 37(1):19-26. PubMed ID: 10965515
[TBL] [Abstract][Full Text] [Related]
12. Rationale for the use of insulin sensitizers to prevent cardiovascular events in type 2 diabetes mellitus.
Fonseca VA
Am J Med; 2007 Sep; 120(9 Suppl 2):S18-25. PubMed ID: 17826042
[TBL] [Abstract][Full Text] [Related]
13. Hyperinsulinemia in patients with colorectal cancer.
Suehiro T; Matsumata T; Shikada Y; Sugimachi K
Hepatogastroenterology; 2005; 52(61):76-8. PubMed ID: 15782998
[TBL] [Abstract][Full Text] [Related]
14. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire?
Gallagher EJ; LeRoith D
Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):485-94. PubMed ID: 23974779
[TBL] [Abstract][Full Text] [Related]
15. Association of diet-induced hyperinsulinemia with accelerated growth of prostate cancer (LNCaP) xenografts.
Venkateswaran V; Haddad AQ; Fleshner NE; Fan R; Sugar LM; Nam R; Klotz LH; Pollak M
J Natl Cancer Inst; 2007 Dec; 99(23):1793-800. PubMed ID: 18042933
[TBL] [Abstract][Full Text] [Related]
16. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
17. Is insulin resistance caused by defects in insulin's target cells or by a stressed mind?
Burén J; Eriksson JW
Diabetes Metab Res Rev; 2005; 21(6):487-94. PubMed ID: 15977304
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
Velicer CM; Dublin S; White E
Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome and breast cancer risk.
Sinagra D; Amato C; Scarpilta AM; Brigandì M; Amato M; Saura G; Latteri MA; Caimi G
Eur Rev Med Pharmacol Sci; 2002; 6(2-3):55-9. PubMed ID: 12708611
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus, hyperglycaemia and cancer.
Simon D; Balkau B
Diabetes Metab; 2010 Jun; 36(3):182-91. PubMed ID: 20554237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
